Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dexcom (DXCM) Profit After Tax (2016 - 2026)

Dexcom has reported Profit After Tax over the past 17 years, most recently at $199.5 million for Q1 2026.

  • Quarterly Profit After Tax rose 89.28% to $199.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $930.4 million through Mar 2026, up 73.84% year-over-year, with the annual reading at $836.3 million for FY2025, 45.14% up from the prior year.
  • Profit After Tax was $199.5 million for Q1 2026 at Dexcom, down from $267.3 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $283.8 million in Q3 2025 and troughed at $48.6 million in Q1 2023.
  • The 5-year median for Profit After Tax is $134.6 million (2024), against an average of $146.7 million.
  • Year-over-year, Profit After Tax surged 1832.08% in 2022 and then tumbled 50.05% in 2023.
  • A 5-year view of Profit After Tax shows it stood at $91.8 million in 2022, then surged by 179.19% to $256.3 million in 2023, then tumbled by 40.81% to $151.7 million in 2024, then skyrocketed by 76.2% to $267.3 million in 2025, then dropped by 25.36% to $199.5 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Profit After Tax are $199.5 million (Q1 2026), $267.3 million (Q4 2025), and $283.8 million (Q3 2025).